3 výsledky
BACKGROUND
Due to increasing incidence of cancer, in general, there is need to develop new therapeutic strategies. The current methods for treatment of tumors, besides radiation therapy and surgical interventions, include tumorcidal chemotherapeutic agents which act directly and are toxic to tumor
The present invention is directed to the use of extracts or of extract compounds from Piper cubeba L. as active components in a medicament for the treatment of cancer.
Uses of Piper cubeba L. compositions are described for example in Hunnius, Pharmazeutisches Worterbuch, 8.sup.th edition, 1998,
FIELD OF THE INVENTION
This invention relates to a method for providing .alpha.-glucosidase inhibition to a subject by administering a pharmaceutical composition comprising a .alpha.-glucosidase inhibitory agent selected from pipataline (formula 1a), sesamin (formula 1b), pellitorine (Formula 1c),